For years, Univadis was the leading portal for physicians across Europe by providing content created specifically for the individual country, in said country’s language. The success of Univadis has not gone unnoticed, and pan-European content sources for physicians are constantly emerging and getting traction among European physicians. New examples continue steadily to emerge. WebMD lately announced a partnership with Medcenter to offer its Medscape content to doctors in Spain and in Portugal while United Business Media’s SearchMedica continues to expand its offerings in a variety of languages and specialties.According to the Centers for Disease Control and Prevention, at least 80 % of women shall possess acquired genital HPV infection by age 50 with about 6. 2 million Us citizens contracting a new genital HPV infections each full year. The U.S. FDA lately approved the initial HPV cervical cancer vaccine that includes some of the L1 capsid protein to guard from this terrible disease. Advanced Tumor Therapeutics is developing a novel HPV vaccine which targets the L2 capsid proteins that people believe should offer broader immune protection to patients at risk of contracting cervical cancer. ACT intends to manufacture its novel HPV vaccine from tobacco mosaic plants, promising to be very cost effective for people at risk of contracting HPV in both developing and developed countries..